Gilead Sciences, Inc. total revenue, net income and dynamics of changes in Euro today
Gilead Sciences, Inc. current income and income for the latest reporting periods. Net revenue Gilead Sciences, Inc. is now 6 217 000 000 €. Information about net revenue is taken from open sources. Net income Gilead Sciences, Inc. - 1 522 000 000 €. Information about net income is used from open sources. The financial graph of Gilead Sciences, Inc. shows the values and changes of such indicators: total assets, net income, net revenue. Gilead Sciences, Inc. financial report on the graph shows the dynamics of assets. A graph of the value of all Gilead Sciences, Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
5 812 180 045 €
+9.36 % ↑
1 422 894 970 €
-19.0426 % ↓
31/03/2021
6 004 766 355 €
+21.62 % ↑
1 616 416 165 €
-12.456 % ↓
31/12/2020
6 937 781 585 €
+26.23 % ↑
1 450 006 635 €
-42.47 % ↓
30/09/2020
6 148 738 645 €
+17.36 % ↑
336 558 600 €
-
31/12/2019
5 496 188 915 €
-
2 520 449 960 €
-
30/09/2019
5 239 095 540 €
-
-1 089 141 025 €
-
30/06/2019
5 314 821 225 €
-
1 757 583 800 €
-
31/03/2019
4 937 127 685 €
-
1 846 397 875 €
-
Show:
to
Gilead Sciences, Inc. financial report charts
The latest dates of Gilead Sciences, Inc. financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Gilead Sciences, Inc. for today is 30/06/2021. Gross profit Gilead Sciences, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Gilead Sciences, Inc. is 4 827 000 000 €
Gilead Sciences, Inc. quarterly report dates
Cost of revenue Gilead Sciences, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Gilead Sciences, Inc. is 1 390 000 000 € Total revenue Gilead Sciences, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Gilead Sciences, Inc. is 6 217 000 000 € Operating income Gilead Sciences, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Gilead Sciences, Inc. is 2 358 000 000 €
Net income Gilead Sciences, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Gilead Sciences, Inc. is 1 522 000 000 € Current assets Gilead Sciences, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Gilead Sciences, Inc. is 14 498 000 000 € Total assets Gilead Sciences, Inc. refers to the total amount of assets owned by a person or entity. Total assets Gilead Sciences, Inc. is 67 984 000 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
4 512 689 895 €
4 732 387 870 €
6 454 446 040 €
5 082 034 860 €
3 922 777 460 €
4 271 489 565 €
4 379 936 225 €
4 042 442 740 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 299 490 150 €
1 272 378 485 €
483 335 545 €
1 066 703 785 €
1 573 411 455 €
967 605 975 €
934 885 000 €
894 684 945 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
5 812 180 045 €
6 004 766 355 €
6 937 781 585 €
6 148 738 645 €
5 496 188 915 €
5 239 095 540 €
5 314 821 225 €
4 937 127 685 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
2 204 458 830 €
2 770 064 255 €
3 661 009 660 €
2 965 455 220 €
1 769 737 305 €
-1 377 085 605 €
2 271 770 550 €
2 091 337 745 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 422 894 970 €
1 616 416 165 €
1 450 006 635 €
336 558 600 €
2 520 449 960 €
-1 089 141 025 €
1 757 583 800 €
1 846 397 875 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 054 550 280 €
986 303 675 €
1 320 057 620 €
1 082 596 830 €
1 027 438 615 €
4 665 076 150 €
1 084 466 600 €
988 173 445 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
3 607 721 215 €
3 234 702 100 €
3 276 771 925 €
3 183 283 425 €
3 726 451 610 €
6 616 181 145 €
3 043 050 675 €
2 845 789 940 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
13 553 962 730 €
12 413 403 030 €
14 954 420 460 €
28 912 253 510 €
28 323 275 960 €
26 514 273 485 €
31 530 866 395 €
31 808 527 240 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
63 557 221 840 €
63 097 258 420 €
63 952 678 195 €
56 913 929 030 €
57 614 157 895 €
55 294 708 210 €
59 094 080 850 €
58 745 368 745 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
6 881 688 485 €
3 800 307 525 €
5 606 505 345 €
12 046 928 110 €
10 873 647 435 €
8 857 100 490 €
10 508 107 400 €
15 824 798 395 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
9 123 542 715 €
8 944 044 795 €
8 377 504 485 €
8 785 114 345 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
36 439 012 645 €
35 908 932 850 €
37 824 512 215 €
38 092 824 210 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
63.25 %
64.94 %
64.01 %
64.84 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
18 426 583 350 €
17 717 940 520 €
17 016 776 770 €
16 309 068 825 €
21 058 284 625 €
19 262 370 540 €
21 143 359 160 €
20 521 660 635 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
2 412 003 300 €
2 710 231 615 €
2 076 379 585 €
1 349 973 940 €
Last revenue report of Gilead Sciences, Inc. was 30/06/2021. According to last financial report total revenue in Gilead Sciences, Inc. was 5 812 180 045 Euro and changed by +9.36% since last year. Net income in Gilead Sciences, Inc. was 1 422 894 970 € in last quartal, net income changes to -19.0426%.
Current cash Gilead Sciences, Inc. - the sum of all of the cash a company has on the date of report. Current cash Gilead Sciences, Inc. is 7 361 000 000 €
Gilead Sciences, Inc. stocks data
GIS.DE stock price
Gilead Sciences, Inc. stock price today, GIS.DE stock quote.
